DealPerfuse Therapeutics, Inc., a Palo Alto-based ophthalmology drug developer, was acquired for $300 million by Bayer AG.
More on MedCity News →
M&A
05/11/2026
Aumet, a Riyadh, Saudi Arabia-based healthtech platform for MENA, raised...
CREATE Medicines, a Cambridge, MA-based clinical-stage CAR-T developer,...
9amHealth, an Encinitas, CA-based virtual chronic care platform, raised...
XCaliber Health, an Andover, MA-based agentic OS for healthcare, raised...
SageOx, a Seattle-based AI agent collaboration platform, raised $15...
Rosarium Health, a U.S.-based aging-at-home healthcare platform, raised $6...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
